FLT3-ITD MRD dynamics predicted relapse risk and shaped response to gilteritinib maintenance in post-transplant AML.

During a live event, Mojtaba Akhtari, MD, discussed trials studying patients with high-risk polycythemia vera.

Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Funding to support MOCART, a ...

But another way of enhancing your endurance performance that's gaining traction – particularly in running circles – lies at ...

Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...

The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...

Discover how iron deficiency causes anxiety symptoms like racing heart and restlessness that mimic panic attacks and anxiety ...

Protagonist Therapeutics Inc. (NASDAQ:PTGX) is one of the best mid cap growth stocks to invest in now. Just as June began, ...

Catch up with the most important stories from around Europe and beyond - latest news, breaking news, World, Business, ...

A high-throughput workflow for wide-targeted metabolomics in dried blood spots (DBS) is presented.

“The benefits people report most often are way more energy, better workouts and faster recovery, higher libido, clearer ...

HU has proven effective in reducing painful episodes, blood transfusion needs ... Hematopoietic Cell Transplantation: Hematopoietic Cell Transplantation (HCT), often referred to as bone marrow ...